Achieving optimal response at 12 months is associated with a better health-related quality of life in patients with chronic myeloid leukemia: A prospective, longitudinal, single center study
Số trang: 11
Loại file: pdf
Dung lượng: 1.82 MB
Lượt xem: 5
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
To assess the relationship between responses within 1 year and health-related quality of life (HRQoL) outcomes by exploring profiles of patients with CML-CP who were treated with front-line imatinib or nilotinib.
Nội dung trích xuất từ tài liệu:
Achieving optimal response at 12 months is associated with a better health-related quality of life in patients with chronic myeloid leukemia: A prospective, longitudinal, single center study
Nội dung trích xuất từ tài liệu:
Achieving optimal response at 12 months is associated with a better health-related quality of life in patients with chronic myeloid leukemia: A prospective, longitudinal, single center study
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Chronic myeloid leukemia Tyrosine kinase inhibitor treatment Quality of life Multivariate analysisGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 142 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 119 0 0 -
12 trang 93 0 0
-
19 trang 74 0 0
-
17 trang 64 0 0
-
9 trang 43 0 0
-
12 trang 38 0 0
-
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
17 trang 37 0 0 -
Expression of deubiquitinase genes and inflammatory response in Myeloid leukemia
8 trang 37 0 0 -
11 trang 37 0 0
-
13 trang 36 0 0
-
Tracking tumor alteration in glioma through serum fibroblast activation protein combined with image
10 trang 34 0 0 -
Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia
9 trang 34 0 0 -
11 trang 33 0 0
-
9 trang 33 0 0
-
CYP4B1 polymorphisms and the risk of breast cancer in Chinese women: A case-control study
14 trang 32 0 0 -
11 trang 32 0 0
-
16 trang 32 0 0